Navigation Links
LSUHSC research finds ginkgo biloba doesn’t improve cognitive function in MS

New Orleans, LA A research study conducted by Dr. Jesus Lovera, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has found that the herbal supplement Ginkgo biloba does not improve cognitive function in patients with Multiple Sclerosis (MS.) Cognitive impairment affects 40-60% of people with MS, most commonly affecting their processing speed, memory, and executive skills. The research findings were published online ahead of print in Neurology on September 5, 2012.

This study followed up on a promising earlier small study by Dr. Lovera and his colleagues that had shown improvement in cognitive function with Ginkgo biloba in people with MS. Some studies have also shown improvement after treatment with Ginkgo biloba in people with Alzheimer's disease.

"Ginkgo biloba supplements are frequently used by people with MS. Ginkgo appeared beneficial in a prior small pilot study we had done," said Dr. Jesus Lovera, a neurologist at LSU Health Sciences Center New Orleans who specializes in MS.

The researchers wanted to conduct a larger more robust study to determine the validity of the preliminary results. One hundred twenty people with MS were randomized to either the group treated with 120 mg of Ginkgo biloba twice a day, or to the group taking matching placebo tablets. Participants were treated for 12 weeks and then underwent a battery of cognitive tests. Participants and their families also answered standardized questionnaires about their cognitive function and social integration. The tests found that there were no statistically significant improvements in cognitive function between the two groups.

"Unfortunately we did not see any improvement with Ginkgo in this new study," notes Dr. Lovera. "Several drugs such as Namenda and Aricept that work for people with Alzheimer's have been tested without success in people with MS. Unfortunately now Ginkgo is added to the list of therapies thought to be effective in Alzheimer's disease that failed to improve cognitive performance in MS."

While the study provides solid evidence, the researchers noted several limitations. Participants were treated for only 12 weeks and perhaps that was not long enough to modify the disease. The median duration of MS was 20 years, and it is possible that Ginkgo may improve cognitive function earlier in the MS disease process. It is also possible that there could have been a positive effect in participants with more severe impairments than those in this study. Additional functional assessments that measure performance in real-life situations may also have detected an effect that was missed by limiting the outcome measures to cognitive tests and questionnaires.

According to the National Institutes of Health, Multiple Sclerosis is an unpredictable disease of the central nervous system, that can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus.

According to the Multiple Sclerosis Association of America, MS is the most common neurological disorder diagnosed in young adults.

Approximately 400,000 individuals have been diagnosed with MS in the United States and as many as two and a half million worldwide, with an estimated 10,000 new cases diagnosed in the United States annually. Most people with MS experience their first symptoms and are diagnosed between the ages of 15 and 50.

Contact: Leslie Capo
Louisiana State University Health Sciences Center

Related biology news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. LSUHSC research finds treating stress prevented new MS brain lesions
3. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
4. Research reveals first evidence of hunting by prehistoric Ohioans
5. Diabetes Research Institute develops oxygen-generating biomaterial
6. APS issues new policy requiring identification of sex or gender in reporting scientific research
7. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
8. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
9. U of Alberta researcher steps closer to understand autoimmune diseases
10. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
11. A project to research biological and chemical aspects of microalgae to fuel approach
Post Your Comments:
(Date:10/6/2015)... Calif. , Oct. 6, 2015  Maverix ... today announced enhancements to its software portfolio with ... analysis kit for differential expression in eukaryotes. The ... which is a cloud-based genomic analysis solution that ... scientific discovery from next-generation sequencing efforts. ...
(Date:10/2/2015)... , Oct. 02 2015 ... of the "Enforcing the Law Using Biometrics" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Enforcing the Law Using Biometrics" ...
(Date:9/30/2015)...  With nearly 300,000 Americans living with spinal cord ... to reach 12,500 annually, the role of Independent Living ... Independent Living (SCRS-IL) is increasingly important. SCRS-IL is ... opening doors to independence for individuals with SCIs ... assistive technology services and education. "In serving ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... ... October 13, 2015 , ... InSphero ... of organotypic 3D cell culture models, has launched a 14 Day Hepatotoxicity ... patent-pending 3D InSightâ„¢ Human Liver Microtissues. The service streamlines toxicity testing of ...
(Date:10/13/2015)... Research and Markets( ) has announced ... for Bone Morphogenetic Protein Growth Factor Therapy - 16 ... --> --> Bone morphogenetic proteins ... bone after a fracture. In nature, these proteins have ... of the skeleton. There are twenty different BMPs that ...
(Date:10/13/2015)... October 13, 2015 " Microbiology Culture ... 2015 - 2023 " , the global microbiology ... anticipated to reach US$7.59 bn by 2023, expanding at a CAGR ... --> " Microbiology Culture Market - Global Industry Analysis, ... , the global microbiology culture market was valued at ...
(Date:10/13/2015)... ... October 13, 2015 , ... AxioMx Inc. , a ... received a Phase I Small Business Innovative Research (SBIR) grant (1R43GM112204-01A1). This Phase ... Sciences (NIGMS), will fund the development of a technique to rapidly convert single-chain ...
Breaking Biology Technology: